Patient demographics, location/type of sealant, and pathologic diagnoses
| Age (yr) | Sex | Level | Sealant | Pathologic Diagnosis |
|---|---|---|---|---|
| 51 | M | T11–L1 | PEGH | Schwannoma |
| 32 | M | T4–7 | Fibrin glue | Schwannoma |
| 37 | F | S1 | PEGH | Ependymoma |
| 67 | F | C4–6 | BSAG | Meningioma |
| 66 | F | L2–3 | BSAG | Schwannoma |
| 41 | M | L1 | Fibrin glue | Ependymoma |
| 21 | M | T12–L1 | PEGH | Ependymoma |
| 34 | F | L4–5 | PEGH | Ependymoma |
| 20 | M | T4–8 | Fibrin glue | Meningioma |
| 73 | F | L1–3 | BSAG | Ependymoma |
| 62 | F | T12–L1 | BSAG | Schwannoma |
| 38 | M | L3 | BSAG | Ependymoma |
| 67 | M | C12 | Fibrin glue | Schwannoma |
| 40 | F | T8–12 | PEGH | Ependymoma |
| 55 | M | L23 | Fibrin glue | Schwannoma |